Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · IEX Real-Time Price · USD
15.76
+0.57 (3.75%)
At close: Mar 28, 2024, 4:00 PM
17.20
+1.44 (9.14%)
After-hours: Mar 28, 2024, 6:32 PM EDT
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for ZNTL stock have an average target of 43.57, with a low estimate of 15 and a high estimate of 70. The average target predicts an increase of 176.46% from the current stock price of 15.76.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 28, 2024.
Analyst Ratings
The average analyst rating for ZNTL stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
Buy | 5 | 4 | 4 | 4 | 3 | 3 |
Hold | 0 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 9 | 9 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +191.88% | Feb 28, 2024 |
Wedbush | Wedbush | Hold Maintains $12 → $15 | Hold | Maintains | $12 → $15 | -4.82% | Feb 28, 2024 |
Wedbush | Wedbush | Buy → Hold Downgrades $38 → $12 | Buy → Hold | Downgrades | $38 → $12 | -23.86% | Nov 8, 2023 |
Stifel | Stifel | Strong Buy Maintains $44 → $36 | Strong Buy | Maintains | $44 → $36 | +128.43% | Nov 7, 2023 |
Morgan Stanley | Morgan Stanley | Buy Maintains $55 → $38 | Buy | Maintains | $55 → $38 | +141.12% | Nov 7, 2023 |
Financial Forecast
Revenue This Year
7.14M
Revenue Next Year
3.93M
from 7.14M
Decreased by -44.92%
EPS This Year
-3.72
from -4.47
EPS Next Year
-3.82
from -3.72
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 36.8M | 40.5M | 363.0M | 496.7M | 837.2M |
Avg | 7.1M | 3.9M | 61.2M | 180.2M | 389.2M |
Low | n/a | n/a | n/a | 54.9M | 148.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 467.0% | 9,129.1% | 711.2% | 364.6% |
Avg | - | -44.9% | 1,456.8% | 194.3% | 116.0% |
Low | - | - | - | -10.4% | -17.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -3.17 | -3.19 | -0.43 | -0.65 | 1.47 |
Avg | -3.72 | -3.82 | -3.26 | -2.04 | -0.26 |
Low | -3.98 | -4.36 | -4.56 | -3.19 | -2.49 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.